Lion Street Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Lion Street Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$86.68 - $100.3 $221,034 - $255,765	2,550 New	2,550 $221,000
Q2 2022 Jul 19, 2022	BUY	$71.48 - $86.85 $180,201 - $218,948	2,521 New	2,521 $201,000
Q1 2022 May 10, 2022	SELL	$74.28 - $92.69 $190,825 - $238,120	-2,569 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$71.72 - $91.47 $184,248 - $234,986	2,569 New	2,569 $226,000
Q2 2020 Jul 20, 2020	SELL	$79.55 - $124.22 $397 - $621	-5 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$71.37 - $96.85 $356 - $484	5 New	5 $0

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lion Street Advisors, LLC with notifications on news.